第5页_Company News_News_Suzhou Linaxin Biotechnology Co., Ltd

Good news! Linaxin Biotechnology has been granted another national second-class medical device registration certificate!
The upper gastrointestinal bleeding and transferrin TF (Changweile) independently developed by Linax...
Good news! Linaxin Biotechnology has been granted a Class II medical device production license!
After obtaining the approval of the "Class II Registration Certificate for Medical Devices", with th...
Linaxin Biotechnology: Signed a strategic cooperation agreement with Xinlimeida Medical
On December 8th, Suzhou Linaxin Biotechnology Co., Ltd. signed a cooperation agreement with Xinlimei...
Good news! Our founder, Dr. Tan Shengwei, won the third prize in the second "Entrepreneurship Yimeng · Win Win Future" high-level talent entrepreneurship competition in Linyi City
On November 23rd, the second "Entrepreneurship Yimeng, Win Win Future" high-level talent entrepreneu...
The signing ceremony for the joint construction of the Lubei Medical Laboratory Center by Binzhou Xinyue Rehabilitation Hospital and Linaxin Biotechnology was successfully held
On the morning of October 10th, the signing ceremony for the establishment of the Lubei Medical Labo...
Linaxin Biotechnology and Kangmeng Holdings Group signed a strategic cooperation agreement to jointly promote early screening of colorectal cancer
On November 6th, Suzhou Linaxin Biotechnology Co., Ltd. and Jiangsu Kangmeng Holdings Group Co., Ltd...
Good news! Linaxin Biotechnology has been approved for Class II medical device registration, and its technological strength has been certified again!
On November 10th, a portable fecal occult blood test kit independently developed by Linaxin Biotechn...
Linaxin Biotechnology successfully conducts registration system assessment for medical device manufacturing enterprises
From August 4th to 6th, 2021, Lixin Nuokang (Shandong) Biomedical Technology Co., Ltd., a wholly-own...